News
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans. The agency is changing ...
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
The FDA is tightening Covid-19 vaccine approval, demanding stronger clinical proof for healthy individuals while easing ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results